血小板来源胞外囊泡中的miR-499促进心肌梗死后炎症细胞生成与心脏重构
该研究在小鼠结扎左前降支诱导心肌梗死(MI)模型及MI患者中,发现循环血小板来源胞外囊泡(pEVs)增多,可增强骨髓造血干/祖细胞(HSPCs)增殖并生成炎症性髓系细胞。MI后心肌细胞产生的S100A8/9诱导pEV分泌,pEVs携带的miR-499通过靶向抑制乳铁蛋白促进髓系生成,而miR-499缺陷的pEVs则减弱紧急髓系生成和心脏重构。
要点
- MI后循环pEVs增多,可促进骨髓HSPC增殖和炎症性髓系细胞生成。
- pEVs携带的miR-499通过下调HSPC中乳铁蛋白促进紧急髓系生成。
- 抑制血小板活化/外泌或HSPC内吞可减轻MI后紧急造血和髓系细胞生成。
核心结论
- MI后生成的pEVs可诱导HSPC增殖和炎症细胞生成,为减轻MI后心脏炎症和重构提供多个治疗靶点。
研究设计与样本
- 研究采用小鼠左前降支结扎诱导MI模型,并使用NanoSight、ImageStream和流式细胞术检测小鼠和MI患者的pEVs。
- 采用微RNA阵列定量pEVs中的microRNA,并通过联体共生、流式细胞术、过继转移实验和转基因小鼠评估pEVs及microRNA对HSPC谱系定向和炎症细胞生成的影响。
- 采用RNA测序、荧光素酶试验、慢病毒介导的体内基因过表达和超声心动图评估乳铁蛋白/乳转铁蛋白在MI后发病机制中的作用。
主要发现
- MI患者和小鼠以及后肢缺血小鼠循环pEVs数量增加,进而增强骨髓HSPC数量和增殖,导致炎症性髓系细胞生成和疾病进展。
- MI后心肌细胞产生的警报素复合物S100A8/9诱导pEV分泌。
- 体内和体外抑制血小板活化和外泌以及HSPC内吞,可显著减少pEV产生、HSPC增殖和紧急造血中的髓系细胞生成。
- 微RNA阵列显示MI后分离的pEVs中miR-499和miR-184货物水平升高,且富集于MI后的网状血小板中。
- 在小鼠和人HSPCs中过表达miR-499和miR-184可增强造血和髓系生成;miR-499缺陷的pEVs在刺激紧急髓系生成和诱导MI后心脏重构方面效率低下。
临床怎么用
- MI后pEVs及其携带的miR-499可能作为减轻心脏炎症和重构的潜在干预靶点。
- 抑制血小板活化/外泌或HSPC内吞可能减少MI后紧急髓系生成。
局限性
- 研究主要基于小鼠MI模型,临床转化需进一步验证。
- 原文未明确报告样本量、P值等具体统计数值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Emergency myelopoiesis by bone marrow hematopoietic stem and progenitor cells (HSPCs) exacerbates disease pathology in various chronic diseases, including myocardial infarction (MI) and atherosclerosis. However, the mechanisms triggering myelopoiesis in the bone marrow after a distant organ injury, such as MI, remain unknown. METHODS: We ligated the left descending coronary artery to induce MI in mice. Platelet-derived extracellular vesicles (pEVs) were detected and enumerated in mice and patients with MI using NanoSight, ImageStream, and flow cytometry. microRNA in pEVs was quantified using a microRNA array. We used parabiosis, flow cytometry, adoptive transfer experiments, and transgenic mice to assess the effects of pEVs and microRNA on HSPC lineage commitment and inflammatory cell generation. In addition, we carried out RNA sequencing, luciferase assay, lentivirus-mediated in vivo gene overexpression, and echocardiography to evaluate the merit of lactoferrin/lactotransferrin in post-MI pathogenesis. RESULTS: In this study, we demonstrate that patients and mice with MI and mice with hindlimb ischemia exhibit an increased number of circulating pEVs, which, in turn, augment HSPC number and proliferation in the bone marrow, leading to inflammatory myeloid cell generation and disease progression. S100A8/9 (S100 calcium-binding protein A8/A9), an alarmin complex produced by cardiomyocytes after MI, induced pEV secretion. In vivo and in vitro inhibition of platelet activation and exocytosis, and HSPC endocytosis, markedly lessened the production of pEV, HSPC proliferation, and myeloid cell generation in emergency hematopoiesis. A microRNA array revealed that pEVs isolated after MI had elevated cargo levels of miR-499 and miR-184, which were enriched in reticulated platelets after MI. miR-499 and miR-184 overexpression in mouse and human HSPCs resulted in enhanced hematopoiesis and myelopoiesis. miR-499-deficient pEVs were inefficient in stimulating emergency myelopoiesis and inducing cardiac remodeling after MI. RNA sequencing analysis, luciferase assay, and lentivirus-mediated in vivo gene overexpression demonstrated that miR-499 bound to the 3' region of lactoferrin/lactotransferrin in HSPC to downregulate this gene, promoting myelopoiesis and unleashing inflammation. CONCLUSIONS: Our study suggests that pEVs generated after MI induce HSPC proliferation and inflammatory cell generation. These discoveries uncover several therapeutic targets to reduce cardiac inflammation and remodeling after MI.
引用
- Ohayon-Steckel, Zhang, Haque, et al. miR-499 in Platelet-Derived Extracellular Vesicles Augments Inflammatory Cell Generation and Cardiac Remodeling After Myocardial Infarction. Circulation. 2025. PMID: 41208706. doi:10.1161/CIRCULATIONAHA.124.073527
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。